Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DiagnoCure axes French subsidiary Samba

This article was originally published in Clinica

Executive Summary

Quebec-based cancer diagnostics company DiagnoCure has announced it will immediately stop funding its Samba Technologies subsidiary, based in Meylan, France. The digital imaging and IT business, which initially partnered with DiagnoCure for the automation of a bladder cancer immunoassay, "is outside of our molecular diagnostics focus", said DiagnoCure president and CEO John Schafer.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT053440

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel